Hello, welcome to Shanghai Chemlin Biopharmaceutical Co., Ltd

language

021-68080707 sales@zhaowusoft.com 3927582691

Company Profile

Home Product Catalog BioPharm Active Pharmaceutical Ingredients Inhibitors

(7R,14R)-11-chloro-1-(difluoromethoxy)-6-[(1-fluoro-cyclopropyl)methyl]-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

Catalog No. : KL-3065206-369

Cas No. : 3065206-36-9

Standard English name : (7R,14R)-11-chloro-1-(difluoromethoxy)-6-((1-fluorocyclopropyl)methyl)-6,7-dihydro-7,14-methanobenzo[f]benzo[4,5]imidazo[1,2-a][1,4]diazocin-5(14H)-one

Molecular Formula : C₂₂H₁₇ClF₃N₃O₂

Molecular Weight : 447.84

MDL No. :

Pack Size	Stock	Purity	Brand	List Price	Your Price	Quantity
Sorry, there is no price information yet

Add to cart Inquiry

Basic information Security information Product Details Related Literature

Basic information

GHS
Smiles	O(C(F)F)C1=C2[C@@]3(N4C(=NC5=CC=C(Cl)C=C54)[C@@](N(CC4(F)CC4)C(=O)C2=CC=C1)([H])C3)[H]
Inchi	InChI=1S/C22H17ClF3N3O2/c23-11-4-5-13-14(8-11)29-15-9-16(19(29)27-13)28(10-22(26)6-7-22)20(30)12-2-1-3-17(18(12)15)31-21(24)25/h1-5,8,15-16,21H,6-7,9-10H2/t15-,16-/m1/s1
InchiKey	JUSPRZBEOVQOCF-HZPDHXFCSA-N
Synonym
Character
Storage Condition
Melting Point
Flash Point
Chemical Stability
Boiling Point
Density
HS Code
Chirality
Biological Activity
Physicochemical Propertie
UN No.
Feature
Useage
Vapor Pressure
Transport Condition
Brand

Security information

Risk Statements
Signal Word
Water Solubility
Dangerous Goods
Safety Statements
Storage Temp.
Hazard Codes
Hazardous Decomposition Products

产品介绍

Sorry, there are currently no product details available

Related Literature

Sorry, there is currently no relevant literature available

History

N-[3-[5-[(7R,14R)-1-(difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]-1-oxido-pyridin-2-yl]-3-oxetanyl]-2-methyl-2-Propanesulfonamide

N-[1-[5-[(7R,14R)-1-(difluoromethoxy)-10-fluoro-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]pyrimidin-2-yl]-1-methylethyl]carbamic acid tert-butyl ester

N-[3-[5-[(7R,14R)-1-(Difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]pyridin-2-yl]-3-oxetanyl]-2-methyl-2-propanesulfinamide

trans-3-amino-3-[5-[(7R,14R)-1-(difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]pyrimidin-2-yl]-1-methylcyclobutane-carbonitrile

cis-3-[5-[(7R,14R)-1-(Difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]pyrimidin-2-yl]-3-hydroxy-1-methylcyclobutane-carbonitrile

2-[4-[(7R,14R)-1-(difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]phenyl]pyrrolidine-1-carboxylic acid tert-butyl ester

[S(R)]-N-[1-[5-[(7R,14R)-1-(difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]-3-fluoropyridin-2-yl]-3-hydroxy-3-(trifluoromethyl)cyclobutyl]-2-methyl-2-Propanesulfinamide

(7R,14R)-11-[2-[cis-1-amino-3-(hydroxymethyl)-3-methylcyclobutyl]pyrimidin-5-yl]-1-(difluoromethoxy)-6,7-dihydro-6-methyl-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[6-(cis-1-amino-3-hydroxy-3-methylcyclobutyl)-5-fluoropyridin-3-yl]-1-(difluoromethoxy)-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-6-cyclopropyl-1-(difluoromethoxy)-11-[6-(dimethylphosphinyl)-pyridin-3-yl]-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-6-cyclopropyl-1-(difluoromethoxy)-11-[4-(dimethylphosphinyl)-3-fluorophenyl]-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

1-[5-[(7R,14R)-1-(difluoromethoxy)-5,6,7,14-tetrahydro-5-oxo-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-11-yl]pyrimidin-2-yl]-3-methyl-3-Azetidinecarbonitrile

(7S,14S)-11-chloro-1-(difluoromethoxy)-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-Chloro-1-(difluoromethoxy)-6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[2-(1-aminocyclobutyl)-pyrimidin-5-yl]-4-cyclopropyl-1-(difluoromethoxy)-6-[(1-fluoro-cyclopropyl)methyl]-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[2-(1-aminocyclobutyl)-pyrimidin-5-yl]-6-[(3,3-difluoro-cyclobutyl)methyl]-1-(difluoromethoxy)-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[2-(1-aminocyclobutyl)-pyrimidin-5-yl]-1-[(3,3-difluoro-cyclobutyloxy)]-6,7-dihydro-6-methyl-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[2-(1-aminocyclobutyl)-pyrimidin-5-yl]-6-(2-butyn-1-yl)-1-(difluoromethoxy)-6,7-dihydro-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[2-(1-amino-1-methylethyl)-pyrimidin-5-yl]-1-(cyclopropylmethoxy)-6,7-dihydro-6-methyl-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

(7R,14R)-11-[2-(1-aminocyclobutyl)-pyrimidin-5-yl]-1-[(2,2-difluoro-cyclopropyloxy)]-6,7-dihydro-6-methyl-7,14-Methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)--one

Shanghai Chemlin Biopharmaceutical Co., Ltd

3rd Floor, Building 6, Dongfang Zhigu, No. 128 Yuantong Road, Datuan Town, Pudong New Area, Shanghai

QQ: 2851865938

TEL: 021-68080707

Email:sales2@chemlin.com.cn

Service Support

Order Service

Custom Synthesis

Commercialized Production

After-Sale Service

About Us

Company Profile

R&D and production base

Global Relations

Chenlin

Scientific Research Website Design

Designed by Zhaowusoft